Journal of Pharmaceutical Policy and Practice: 2023, vol: 16, issue: 1
1)- Phei Ching Lim, Retha Rajah, Yen Li Lim, Jason Lye Hin Kam, Te Ying Wong, Vivegananth Krishnanmurthi, Chee Tao Chang, Mun Teng Cheah, Nur Dayana Kamaruzzaman, Wee Toong Tan, Eng Seng Lee, Hadzliana Zainal. Development and validation of patient diabetes knowledge questionnaire (PDKQ).Journal of pharmaceutical policy and practice. 2023, 16 (1): 121
2)- Preechaya Tajai, Akarawat Kornjirakasemsan. Predicting mortality in paraquat poisoning through clinical findings, with a focus on pulmonary and cardiovascular system disorders.Journal of pharmaceutical policy and practice. 2023, 16 (1): 123
3)- Yeniewa Kerie Anagaw, Liknaw Workie Limenh, Derso Teju Geremew, Minichil Chanie Worku, Misganaw Gashaw Dessie, Tewodros Ayalew Tessema, Teshome Bitew Demelash, Wondim Ayenew. Assessment of prescription completeness and drug use pattern using WHO prescribing indicators in private community pharmacies in Addis Ababa: a cross-sectional study.Journal of pharmaceutical policy and practice. 2023, 16 (1): 124
4)- Asmaa A Elsayed, Hoda M Rabea, Salman Ahmed Salman, Engy A Wahsh. The preparedness and knowledge of pharmacists and general practitioners in managing human monkeypox: a highly spreading infectious disease.Journal of pharmaceutical policy and practice. 2023, 16 (1): 125
5)- Amare Zewdie, Abebaw Wasie Kasahun, Haimanot Abebe Adane, Ayenew Mose. Willingness to vaccinate their daughters against human papillomavirus among parents of Ethiopian adolescent girls: a systematic review and meta-analysis.Journal of pharmaceutical policy and practice. 2023, 16 (1): 126
6)- H Laetitia Hattingh, Catherine Edmunds, Brigid M Gillespie. Medication management of COVID-19 patients during transition to virtual models of care: a qualitative study.Journal of pharmaceutical policy and practice. 2023, 16 (1): 127
7)- Joya Namnoum, Aline Hajj, Katia Iskandar, Hala Sacre, Marwan Akel, Rony M Zeenny, Chadia Haddad, Pascale Salameh. Assessing and validating the specialized competency framework for pharmacists in sales and marketing (SCF-PSM): a cross-sectional analysis in Lebanon.Journal of pharmaceutical policy and practice. 2023, 16 (1): 128
8)- Khawla Abu Hammour, Hamza Alhamad, Fahmi Y Al-Ashwal, Abdulsalam Halboup, Rana Abu Farha, Adnan Abu Hammour. Correction: ChatGPT in pharmacy practice: a cross-sectional exploration of Jordanian pharmacists' perception, practice, and concerns.Journal of pharmaceutical policy and practice. 2023, 16 (1): 129
9)- Nattanichcha Kulthanachairojana, Krittaphas Kangwanrattanakul, Thitiya Khongmee, Nampratai Pawasan, Sitanan Chityam, Suphannika Pornwattanakavee. Health-related quality of life and willingness to pay measurement among patients on warfarin in Thailand.Journal of pharmaceutical policy and practice. 2023, 16 (1): 130
10)- Salwa Selim Ibrahim Abougalambou, Tief Naif Alenezi. Knowledge and information sources of potential drug-drug interactions of healthcare professionals among Buraydah Hospitals.Journal of pharmaceutical policy and practice. 2023, 16 (1): 131
11)- Hadeer Ehab Barakat, Christine Nazir Aziz, Salwa Selim Ibrahim Abougalambou. Evaluation of the knowledge, practices, and attitudes of community pharmacists towards adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs): a cross-sectional study.Journal of pharmaceutical policy and practice. 2023, 16 (1): 132
12)- Jack C Collins, Jie Hu, Sara S McMillan, Claire L O'Reilly, Sarira El-Den, Fiona Kelly, Jean Spinks, Toni Riley, Amanda J Wheeler. Medication-related problems identified by community pharmacists: a descriptive case study of two Australian populations.Journal of pharmaceutical policy and practice. 2023, 16 (1): 133
13)- Ju-Ying Ang, Guat-See Ooi, Fatimatuzzahra' Abd Aziz, Seng-Fah Tong. Risk-taking in consumers' online purchases of health supplements and natural products: a grounded theory approach.Journal of pharmaceutical policy and practice. 2023, 16 (1): 134
14)- Reko Ravela, Marja Airaksinen, Alan Lyles. State of the European Union's early notification obligation for drug shortages: enforcement and compliance in eight European countries (2020-2022).Journal of pharmaceutical policy and practice. 2023, 16 (1): 135
15)- Joya Namnoum, Aline Hajj, Katia Iskandar, Hala Sacre, Marwan Akel, Rony M Zeenny, Chadia Haddad, Pascale Salameh. Correction: Assessing and validating the specialized competency framework for pharmacists in sales and marketing (SCF-PSM): a cross-sectional analysis in Lebanon.Journal of pharmaceutical policy and practice. 2023, 16 (1): 136
17)- Dimple Butani, Dian Faradiba, Saudamini Vishwanath Dabak, Wanrudee Isaranuwatchai, Evan Huang-Ku, Kumaree Pachanee, Budsadee Soboon, Anthony J Culyer, Yot Teerawattananon. Expanding access to high-cost medicines under the Universal Health Coverage scheme in Thailand: review of current practices and recommendations.Journal of pharmaceutical policy and practice. 2023, 16 (1): 138
18)- Petra Brhlikova, Aashna Mehta, Patricia McGettigan, Allyson M Pollock, Peter Roderick, Habib Hasan Farooqui. Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics.Journal of pharmaceutical policy and practice. 2023, 16 (1): 139
19)- Araba Ata Hutton-Nyameaye, Farrukh Ishaque Saah, Israel Bedzina, Samuel Owusu Somuah, Kofi Boamah Mensah, Kwabena Obeng Duedu, Kwame Ohene Buabeng. Management of sexually transmitted infections: a qualitative assessment of community pharmacy practices in the Ho Municipality, Ghana.Journal of pharmaceutical policy and practice. 2023, 16 (1): 140
20)- Obinna Onwujekwe, Charles Orjiakor, Pamela Ogbozor, Ifunanya Agu, Prince Agwu, Tom Wright, Dina Balabanova, Jillian Kohler. Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria.Journal of pharmaceutical policy and practice. 2023, 16 (1): 141
21)- Billy Said Mkamba, Eugene Rutungwa, Peter Ndirangu Karimi, Joseph Lune Ngenzi. Factors that influence the availability of childhood vaccine in healthcare facilities at Tana River County, Kenya.Journal of pharmaceutical policy and practice. 2023, 16 (1): 142
22)- Lindemberg Assunção-Costa, Charleston Ribeiro Pinto, Juliana Ferreira Fernandes Machado, Cleidenete Gomes Valli, Luis Eugenio Portela Fernandes de Souza. Assessing the severity of medication administration errors identified in an observational study using a valid and reliable method.Journal of pharmaceutical policy and practice. 2023, 16 (1): 143
23)- Green Sadru, Mulatedzi Makhado, Omary Swalehe, Stany Banzimana, Domina Asingizwe, Shital Mahindra Maru. Assessment of vaccine management performance in health facilities of Mwanza Region, Tanzania: a cross-sectional study.Journal of pharmaceutical policy and practice. 2023, 16 (1): 144
24)- Japheth Araka Ayako, Peter Ndirangu Karimi, Eugene Rutungwa, Joseph Lune Ngenzi, Kelvin Wangira Nyongesa, Racheal Habona Jillo, Miheso Hassler Kavere, Abdul Galgalo Shambaro. Factors affecting the availability of tracer health commodities in public facilities at Tana River County, Kenya.Journal of pharmaceutical policy and practice. 2023, 16 (1): 145
27)- Saron Naji Gebremariam, Fasiel Dula Sema, Abdisa Gemedi Jara, Banchamlak Teferi Mekonen, Gizework Alemnew Mekonnen. Medication error and associated factors among adults admitted to emergency ward at the university of Gondar comprehensive specialized hospital, North-West Ethiopia: a cross-sectional study, 2022.Journal of pharmaceutical policy and practice. 2023, 16 (1): 148
28)- Alambo K Mssusa, Lone Holst, Godeliver Kagashe, Sheila Maregesi. Safety profile of herbal medicines submitted for marketing authorization in Tanzania: a cross-sectional retrospective study.Journal of pharmaceutical policy and practice. 2023, 16 (1): 149
29)- Daniel Pyuza, Shiferaw Mitiku, Omary Swalehe, Vedaste Kagisha, Kato Jonas Njunwa. Performance of Jazia Prime Vendor System in ensuring availability of health commodities in Singida Region, Tanzania: a pre- and post-evaluation study.Journal of pharmaceutical policy and practice. 2023, 16 (1): 150
30)- Faezeh Ghaempanah, Maziar Nikouei, Mojtaba Cheraghi, Arman Jahangiri, Yousef Moradi. Does tocilizumab have an effect on the clinical outcomes in COVID-19 patients? A meta-analysis of randomized control trials.Journal of pharmaceutical policy and practice. 2023, 16 (1): 151
31)- Ewunetie Mekashaw Bayked, Getachew Nigatu Taye, Segenet Zewdie, Teshager Aklilu, Mesfin Haile Kahissay, Husien Nurahmed Toleha. Pharmacy professionals' perceptions of their professional duties in the Ethiopian health care system: a mixed methods study.Journal of pharmaceutical policy and practice. 2023, 16 (1): 152
33)- Muhammad Abbas, Kashif Kashmiri, Inayat Ur Rehman, Zahid Ali, Aziz Ur Rahman, Asad Khalil, Long Chiau Ming, Muhammad Shafique, Tahir Mehmood Khan. Evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in Pakistan.Journal of pharmaceutical policy and practice. 2023, 16 (1): 154
34)- Marcela Vieira, Tatiana Andia, Obaida Karim, Sanjida Ahmed Srishti, Sebastian Alfonso Pineda, Adrian Alonso Ruiz, Kaitlin Large, Yiqi Liu, Suerie Moon, Nahitun Naher, Azizah Siddiqui, Syed Masud Ahmed. Rising pharmaceutical innovation in the Global South: a landscape study.Journal of pharmaceutical policy and practice. 2023, 16 (1): 155
35)- Elizabeth F Peacocke, Adam Fusheini, Pauline Norris. Community pharmacists' views about prescription medicine co-payments and potential implications for equitable access to medicines: a critical realist interpretation.Journal of pharmaceutical policy and practice. 2023, 16 (1): 156
36)- Amir H Zargarzadeh, Zoha Abdi, Sarah Mousavi. Evaluation of outpatient prescription patterns of COVID-19 drugs in Iran: comparison of real practice with local therapeutic recommendations.Journal of pharmaceutical policy and practice. 2023, 16 (1): 157
37)- Tim Killeen, Vanessa Kermer, Rahel Troxler Saxer. mRNA vaccine development during the COVID-19 pandemic: a retrospective review from the perspective of the Swiss affiliate of a global biopharmaceutical company.Journal of pharmaceutical policy and practice. 2023, 16 (1): 158
38)- Bayan F Ababneh, Siew Chin Ong, Louai Alsaloumi, Hisham Z Aljamal, Rabia Hussain. Reliability and validity of the Malay version of the drive-thru community pharmacy service questionnaire and the Malaysian public's awareness, attitudes, and perceptions of drive-thru community pharmacy during COVID-19.Journal of pharmaceutical policy and practice. 2023, 16 (1): 159
39)- Moza Al Hail, Pallivalapila Abdulrouf, Derek Stewart, Wessam Elkassem, Rajvir Singh, Rasha Al Enany, Aftab Mohammed Azad, Asma Tarannum, Binny Thomas. Behaviour and associated determinants of COVID-19 vaccine acceptance and advocacy: a nationwide survey of pharmacy professionals in Qatar.Journal of pharmaceutical policy and practice. 2023, 16 (1): 160
40)- Jaime Barrio-Cortes, Beatriz Benito-Sánchez, Ana Isabel Villimar-Rodriguez, Miguel Rujas, Peña Arroyo-Gallego, Jim Carlson, Beatriz Merino-Barbancho, Ana Roca-Umbert, Andrés Castillo-Sanz, Francisco Lupiáñez-Villanueva, Giuseppe Fico, Tomás Gómez-Gascón. Differences in healthcare service utilization in patients with polypharmacy according to their risk level by adjusted morbidity groups: a population-based cross-sectional study.Journal of pharmaceutical policy and practice. 2023, 16 (1): 161
41)- Yapp Wen Xuan, Hui Poh Goh, Inayat Ur Rehman, Naeem Shafqat, Yaser Mohammed Al-Worafi, Long Chiau Ming, Andi Hermansyah. Assessing consumers' perception and demand on the community pharmacists' dispensing.Journal of pharmaceutical policy and practice. 2023, 16 (1): 162
42)- Sandrella Bou Malhab, Chadia Haddad, Hala Sacre, Aline Hajj, Rony M Zeenny, Marwan Akel, Pascale Salameh. Adherence to treatment and harmful effects of medication shortages in the context of severe crises: scale validation and correlates.Journal of pharmaceutical policy and practice. 2023, 16 (1): 163
43)- Behailu Terefe Tesfaye, Dula Dessalegn Bosho, Gashahun Mekonnen Dissassa, Mikiyas Gashaw Tesfaye, Mengist Awoke Yizengaw. Potentially inappropriate medicine use and predicting risk factors in hospitalized older adult patients: findings of a prospective observational study from Ethiopia.Journal of pharmaceutical policy and practice. 2023, 16 (1): 164
44)- Karen Ka Yan Ng, Peter Chengming Zhang. Advancing medical affair capabilities and insight generation through machine learning techniques.Journal of pharmaceutical policy and practice. 2023, 16 (1): 165
45)- Nai-Chung Nelson Chang, Catherine Chanfreau-Coffinier, Jill Bates, Sony Tuteja, Tori R Anglin, Von R Moore, Jason Hou, Akbar Waljee, Kathryn M Pridgen, David W Oslin, Deepak Voora, Scott L DuVall, Francesca E Cunningham, Julie A Lynch. Pharmacogenetic testing and monitoring of complete blood counts among Veterans newly prescribed thiopurine treatments: a retrospective cohort study.Journal of pharmaceutical policy and practice. 2023, 16 (1): 166
46)- Tim Killeen, Vanessa Kermer, Rahel Troxler Saxer. Correction: mRNA vaccine development during the COVID-19 pandemic: a retrospective review from the perspective of the Swiss affiliate of a global biopharmaceutical company.Journal of pharmaceutical policy and practice. 2023, 16 (1): 167
47)- Miradije Imeri, Shaip Krasniqi, Lul Raka, Isme Humolli, Kreshnik Hoti, Zana Imeri, Valbona Zhjeqi. Evaluation of parents' attitudes and practices related to antibiotic use for their children in Kosovo: a cross-sectional survey.Journal of pharmaceutical policy and practice. 2023, 16 (1): 168
48)- Unaiza Waheed, Mike Stedman, Mark Davies, Emma Solomon, David Taylor, Adrian Heald, Ram Prakash Narayanan, John Warner-Levy. Changes in prescribing of psychotropic vs some physical health medication in primary care through the COVID-19 pandemic in England: a national-level survey.Journal of pharmaceutical policy and practice. 2023, 16 (1): 169
49)- Ayana Kani, Manako Hanya, Hiroyuki Kamei, Kenta Murotani. Development of the Pharmacist's Stress Scale for Home Care (PSS) and evaluation of its reliability and validity.Journal of pharmaceutical policy and practice. 2023, 16 (1): 170
50)- Faten Naif Aldajani, Mohammed Aldosari. Pharmacist-led vaccination services in the Middle East.Journal of pharmaceutical policy and practice. 2023, 16 (1): 171